|
1
|
Zagon IS, Donahue RN and McLaughlin PJ:
Opioid growth factor-opioid growth factor receptor axis is a
physiological determinant of cell proliferation in diverse human
cancers. Am J Physiol Regul Integr Comp Physiol. 297:R1154–R1161.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kren NP, Zagon IS and McLaughlin PJ:
Modulation of the opioid growth factor receptor alters the
proliferation and progression of cancer. Trends Cancer Res.
9:53–64. 2013.
|
|
3
|
Fanning J, Hossler CA, Kesterson JP,
Donahue RN, McLaughlin PJ and Zagon IS: Expression of the opioid
growth factor-opioid growth factor receptor axis in human ovarian
cancer. Gynecol Oncol. 124:319–324. 2012. View Article : Google Scholar
|
|
4
|
Zagon IS, Porterfield NK and McLaughlin
PJ: Opioid growth factor-opioid growth factor receptor axis
inhibits proliferation of triple negative breast cancer. Exp Biol
Med (Maywood). 238:589–599. 2013. View Article : Google Scholar
|
|
5
|
Donahue RN, McLaughlin PJ and Zagon IS:
Cell proliferation of human ovarian cancer is regulated by the
opioid growth factor-opioid growth factor receptor axis. Am J
Physiol Regul Integr Comp Physiol. 296:R1716–R1725. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Campbell AM, Zagon IS and McLaughlin PJ:
Astrocyte proliferation is regulated by the OGF-OGFr axis in vitro
and in experimental autoimmune encephalomyelitis. Brain Res Bull.
90:43–51. 2013. View Article : Google Scholar
|
|
7
|
Donahue RN, McLaughlin PJ and Zagon IS:
Low-dose naltrexone suppresses ovarian cancer and exhibits enhanced
inhibition in combination with cisplatin. Exp Biol Med (Maywood).
236:883–895. 2011. View Article : Google Scholar
|
|
8
|
Forbes SA, Bindal N, Bamford S, Cole C,
Kok CY, Beare D, Jia M, Shepherd R, Leung K, Menzies A, et al:
COSMIC: mining complete cancer genomes in the Catalogue of Somatic
Mutations in Cancer. Nucleic Acids Res. 39:D945–D950. 2011.
View Article : Google Scholar :
|
|
9
|
Bamford S, Dawson E, Forbes S, Clements J,
Pettett R, Dogan A, Flanagan A, Teague J, Futreal PA, Stratton MR
and Wooster R: The COSMIC (Catalogue of Somatic Mutations in
Cancer) database and website. Br J Cancer. 91:355–358.
2004.PubMed/NCBI
|
|
10
|
Cheng F, McLaughlin PJ, Verderame MF and
Zagon IS: Dependence on nuclear localization signals of the opioid
growth factor receptor in the regulation of cell proliferation. Exp
Biol Med (Maywood). 234:532–541. 2009. View Article : Google Scholar
|
|
11
|
Mayya V, Lundgren DH, Hwang SI, Rezaul K,
Wu L, Eng JK, Rodionov V and Han DK: Quantitative phosphoproteomic
analysis of T cell receptor signaling reveals system-wide
modulation of protein-protein interactions. Sci Signal. 2:ra462009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dephoure N, Zhou C, Villén J, Beausoleil
SA, Bakalarski CE, Elledge SJ and Gygi SP: A quantitative atlas of
mitotic phosphorylation. Proc Natl Acad Sci USA. 105:10762–10767.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Han G, Ye M, Zhou H, Jiang X, Feng S,
Jiang X, Tian R, Wan D, Zou H and Gu J: Large-scale phosphoproteome
analysis of human liver tissue by enrichment and fractionation of
phosphopeptides with strong anion exchange chromatography.
Proteomics. 8:1346–1361. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Oppermann FS, Gnad F, Olsen JV, Hornberger
R, Greff Z, Kéri G, Mann M and Daub H: Large-scale proteomics
analysis of the human kinome. Mol Cell Proteomics. 8:1751–1764.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Olsen JV, Blagoev B, Gnad F, Macek B,
Kumar C, Mortensen P and Mann M: Global, in vivo, and site-specific
phosphorylation dynamics in signaling networks. Cell. 127:635–648.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Olsen JV, Vermeulen M, Santamaria A, Kumar
C, Miller ML, Jensen LJ, Gnad F, Cox J, Jensen TS, Nigg EA, et al:
Quantitative phosphoproteomics reveals widespread full
phosphorylation site occupancy during mitosis. Sci Signal.
3:ra32010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zanivan S, Gnad F, Wickström SA, Geiger T,
Macek B, Cox J, Fässler R and Mann M: Solid tumor proteome and
phosphoproteome analysis by high resolution mass spectrometry. J
Proteome Res. 7:5314–5326. 2008. View Article : Google Scholar
|
|
18
|
Wiśniewski JR, Nagaraj N, Zougman A, Gnad
F and Mann M: Brain phosphoproteome obtained by a FASP-based method
reveals plasma membrane protein topology. J Proteome Res.
9:3280–3289. 2010. View Article : Google Scholar
|
